|
Volumn 69, Issue 6, 2007, Pages 609-611
|
SCN1A mutation associated with atypical panayiotopoulos syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE;
CARBAMAZEPINE;
ETIRACETAM;
LAMOTRIGINE;
PROTEIN DERIVATIVE;
SCN1A PROTEIN;
TOPIRAMATE;
UNCLASSIFIED DRUG;
VALPROIC ACID;
NERVE PROTEIN;
SODIUM CHANNEL;
SODIUM CHANNEL, VOLTAGE GATED, TYPE I, ALPHA PROTEIN;
SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, ALPHA PROTEIN;
ARTICLE;
ATYPICAL PANAYIOTOPOULOS SYNDROME;
CARDIOPULMONARY INSUFFICIENCY;
CASE REPORT;
CEREBROSPINAL FLUID;
CHILD;
COGNITION;
COMPUTER ASSISTED TOMOGRAPHY;
ELECTROCARDIOGRAM;
ELECTROENCEPHALOGRAM;
FEMALE;
GENE MUTATION;
HUMAN;
INTENSIVE CARE UNIT;
LANGUAGE;
NEUROLOGIC EXAMINATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARENT;
PRIORITY JOURNAL;
PSYCHOMOTOR DEVELOPMENT;
SEIZURE;
AMINO ACID SUBSTITUTION;
CLASSIFICATION;
ELECTROENCEPHALOGRAPHY;
FEVER;
FOCAL EPILEPSY;
GENETIC PREDISPOSITION;
GENETICS;
HEART ARREST;
HETEROZYGOTE;
MISSENSE MUTATION;
POINT MUTATION;
SYNDROME;
VOMITING;
AMINO ACID SUBSTITUTION;
CHILD;
ELECTROENCEPHALOGRAPHY;
EPILEPSIES, PARTIAL;
FEMALE;
FEVER;
GENETIC PREDISPOSITION TO DISEASE;
HEART ARREST;
HETEROZYGOTE;
HUMANS;
MUTATION, MISSENSE;
NERVE TISSUE PROTEINS;
POINT MUTATION;
SODIUM CHANNELS;
SYNDROME;
VOMITING;
|
EID: 34249818138
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000266666.10404.53 Document Type: Article |
Times cited : (58)
|
References (7)
|